Our long-term goal of this proposal is to elucidate the structure and function relationship of peptide hormone receptors using recently developed biochemical techniques, such as microsequencing and hybridoma technology. Our understanding of the hormone-receptor interaction (the first step of peptide hormone action) and following biological events has greatly advanced at cellular level in the last 10 years. However, our knowledge of the hormone-receptor interaction at molecular level is still limited, since it has been extremely difficult to purify biologically active receptors which are membrane proteins and are not abundant. The insulin receptor is thought to play an important role in insulin action. Abnormality in the receptor number and/or structure have been observed in some forms of diabetes. The receptor is a large glycoprotein with Mr=300,000-350,000 which is composed of two Mr=125,000(Alpha) and two Mr=90,000(Beta) subunits and is only available in very small quantities. We have recently succeeded in purifying biologically active insulin receptor from human placental membranes. Our ongoing project applies newly developed genetic engineering technology to determine amino acid sequence of the receptor. The projects proposed here will be performed simultaneously with the ongoing project from a different standpoint based on protein chemistry: 1) We will determine specific domains of the receptor and systematically investigate each domain in relation to insulin action using a variety of monoclonal antibodies against the receptor. 2) We will study the tertiary structure-function relationship in the insulin receptor molecule using enzymatic and chemical modification techniques, and also evaluate conformational changes of the receptor upon insulin binding by means of optical spectroscopy. These studies on the insulin receptor molecule would not only reveal the domain structure of the receptor in relation to its biological activities but also allows us to understand the exact mechanism of insulin-receptor interaction and the role of the receptor in insulin action, which would provide us new sights towards understanding diabetes and eventually curing the disease or preventing its complications.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK034427-03
Application #
3232771
Study Section
Cellular Biology and Physiology Subcommittee 1 (CBY)
Project Start
1984-07-01
Project End
1987-06-30
Budget Start
1986-07-01
Budget End
1987-06-30
Support Year
3
Fiscal Year
1986
Total Cost
Indirect Cost
Name
City of Hope/Beckman Research Institute
Department
Type
DUNS #
City
Duarte
State
CA
Country
United States
Zip Code
91010
Li, S; Termini, J; Hayward, A et al. (1998) The carboxyl-terminal domain of insulin-like growth factor-I receptor interacts with the insulin receptor and activates its protein tyrosine kinase. FEBS Lett 421:45-9
Kimura, G; Kasuya, J; Giannini, S et al. (1996) Insulin-like growth factor (IGF) system components in human prostatic cancer cell-lines: LNCaP, DU145, and PC-3 cells. Int J Urol 3:39-46
Hashimoto, R; Fujiwara, H; Higashihashi, N et al. (1995) N-terminal deletion mutants of insulin-like growth factor-II (IGF-II) show Thr7 and Leu8 important for binding to insulin and IGF-I receptors and Leu8 critical for all IGF-II functions. J Biol Chem 270:18013-8
Giannini, S; Mohan, S; Kasuya, J et al. (1994) Characterization of insulin-like growth factor-binding proteins produced by cultured fibroblasts from patients with noninsulin-dependent diabetes mellitus, insulin-dependent diabetes mellitus, or obesity. J Clin Endocrinol Metab 79:1824-30
Kasuya, J; Li, S L; Orr, S et al. (1994) The purified COOH-terminal domain of the insulin receptor carries activity to stimulate protein kinase activity or autophosphorylation of the beta subunit domain of insulin receptor. Biochem Biophys Res Commun 200:777-83
Kasuya, J; Paz, I B; Maddux, B A et al. (1993) Characterization of human placental insulin-like growth factor-I/insulin hybrid receptors by protein microsequencing and purification. Biochemistry 32:13531-6
Yan, P F; Li, S L; Liang, S J et al. (1993) The role of COOH-terminal and acidic domains in the activity and stability of human insulin receptor protein tyrosine kinase studied by purified deletion mutants of the beta subunit domain. J Biol Chem 268:22444-9
Li, S L; Kato, J; Paz, I B et al. (1993) Two new monoclonal antibodies against the alpha subunit of the human insulin-like growth factor-I receptor. Biochem Biophys Res Commun 196:92-8
Xiong, L; Kasuya, J; Li, S L et al. (1992) Growth-stimulatory monoclonal antibodies against human insulin-like growth factor I receptor. Proc Natl Acad Sci U S A 89:5356-60
Li, S L; Yan, P F; Paz, I B et al. (1992) Human insulin receptor beta-subunit transmembrane/cytoplasmic domain expressed in a baculovirus expression system: purification, characterization, and polylysine effects on the protein tyrosine kinase activity. Biochemistry 31:12455-62

Showing the most recent 10 out of 21 publications